| Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells N Sethi, X Dai, CG Winter, Y Kang Cancer cell 19 (2), 192-205, 2011 | 667 | 2011 |
| Comparative molecular analysis of gastrointestinal adenocarcinomas Y Liu, NS Sethi, T Hinoue, BG Schneider, AD Cherniack, F Sanchez-Vega, ... Cancer cell 33 (4), 721-735. e8, 2018 | 478 | 2018 |
| Unravelling the complexity of metastasis—molecular understanding and targeted therapies N Sethi, Y Kang Nature Reviews Cancer 11 (10), 735-748, 2011 | 419 | 2011 |
| Oesophageal adenocarcinoma and gastric cancer: should we mind the gap? Y Hayakawa, N Sethi, AR Sepulveda, AJ Bass, TC Wang Nature Reviews Cancer 16 (5), 305-318, 2016 | 137 | 2016 |
| Notch signalling in cancer progression and bone metastasis N Sethi, Y Kang British journal of cancer 105 (12), 1805-1810, 2011 | 94 | 2011 |
| Rabconnectin-3 is a functional regulator of mammalian Notch signaling N Sethi, Y Yan, D Quek, T Schupbach, Y Kang Journal of biological chemistry 285 (45), 34757-34764, 2010 | 89 | 2010 |
| Dysregulation of developmental pathways in bone metastasis N Sethi, Y Kang Bone 48 (1), 16-22, 2011 | 46 | 2011 |
| Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model NS Sethi, O Kikuchi, GN Duronio, MD Stachler, JM McFarland, ... Nature genetics 52 (2), 219-230, 2020 | 45 | 2020 |
| Interaction of a Neurotropic Strain of Borrelia turicatae with the Cerebral Microcirculation System N Sethi, M Sondey, Y Bai, KS Kim, D Cadavid Infection and immunity 74 (11), 6408-6418, 2006 | 30 | 2006 |
| An enhancer-driven stem cell–like program mediated by SOX9 blocks intestinal differentiation in colorectal cancer X Liang, GN Duronio, Y Yang, P Bala, P Hebbar, S Spisak, P Sahgal, ... Gastroenterology 162 (1), 209-222, 2022 | 29 | 2022 |
| Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma N Sethi, O Kikuchi, J McFarland, Y Zhang, M Chung, N Kafker, M Islam, ... JCI insight 4 (15), 2019 | 28 | 2019 |
| Notch signaling: mediator and therapeutic target of bone metastasis N Sethi, Y Kang BoneKEy reports 1, 2012 | 19 | 2012 |
| Jagged1 as a marker and therapeutic target for breast cancer bone metastasis Y Kang, N Sethi US Patent App. 14/815,607, 2015 | 18 | 2015 |
| Safety of Serial Monthly Administration of Triple‐Dose Gadopentetate Dimeglumine in Multiple Sclerosis Patients: Preliminary Results of the BECOME Trial LJ Wolansky, MH Haghighi, E Sevdalis, SD Cook, N Sethi, J Liu, ... Journal of Neuroimaging 15 (3), 289-290, 2005 | 14 | 2005 |
| YAP1 and PRDM14 converge to promote cell survival and tumorigenesis M Kim, SH Ly, Y Xie, GN Duronio, D Ford-Roshon, JH Hwang, R Sulahian, ... Developmental cell 57 (2), 212-227. e8, 2022 | 11 | 2022 |
| Early TP53 Alterations Shape Gastric and Esophageal Cancer Development P Sahgal, BM Huffman, DT Patil, WK Chatila, R Yaeger, JM Cleary, ... Cancers 13 (23), 5915, 2021 | 11 | 2021 |
| Tumor control with PD-1 inhibition in a patient with concurrent metastatic melanoma and renal cell carcinoma ME Marmarelis, MR Davis, NS Sethi, KM Krajewksi, RR McKay, ... Journal for ImmunoTherapy of Cancer 4, 1-5, 2016 | 11 | 2016 |
| Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation P Bala, JP Rennhack, D Aitymbayev, C Morris, SM Moyer, GN Duronio, ... Science Advances 9 (13), eadf0927, 2023 | 10 | 2023 |
| Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers WK Chatila, H Walch, JF Hechtman, SM Moyer, V Sgambati, DM Faleck, ... Nature communications 14 (1), 110, 2023 | 10 | 2023 |
| Emerging role of targeted therapy in metastatic pancreatic adenocarcinoma BM Huffman, H Ellis, AC Jordan, WA Freed-Pastor, K Perez, DA Rubinson, ... Cancers 14 (24), 6223, 2022 | 10 | 2022 |
Yibin KangWarner-Lambert/Parke-Davis Professor of Molecular Biology, Princeton UniversityVerified email at princeton.edu
